razoxane has been researched along with Carcinoma, Anaplastic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carr, DT; Coles, DT; Eagan, RT; Frytak, S; Rubin, J | 1 |
| Berman, M; Blessing, JA; Homesley, HD | 1 |
1 trial(s) available for razoxane and Carcinoma, Anaplastic
| Article | Year |
|---|---|
ICRF-159 versus polychemotherapy in non-small cell lung cancer.
Topics: Adult; Aged; Bleomycin; Carcinoma; Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Lung Neoplasms; Male; Middle Aged; Piperazines; Prognosis; Razoxane; Vincristine | 1976 |
1 other study(ies) available for razoxane and Carcinoma, Anaplastic
| Article | Year |
|---|---|
ICRF-159 (razoxane) in patients with advanced nonsquamous cell carcinoma of the cervix. A Gynecologic Oncology Group study.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma; Female; Humans; Middle Aged; Piperazines; Razoxane; Uterine Cervical Neoplasms | 1986 |